© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Grace Halsey
Articles
In Patients with NAFLD, Type 2 Diabetes Significantly Ups Risk for Hepatic Decompensation, Hepatocellular Carcinoma
July 11, 2023
In patients with NAFLD, type 2 diabetes was found to be an independent predictor of both hepatic decompensation and incident HCC, according to meta-analysis authors. .
Inclisiran Label Expanded to Include Primary Prevention Population
July 10, 2023
The expanded indication widens the patient population eligible for the novel siRNA therapy to include high-risk patients on maximum statin Rx who have not had a CV event.
Physiatry and Primary Care: A Potent Pairing for Older and Aging Adults
July 07, 2023
For older adults who feel limited by physical changes associated with aging, physiatry can help maintain strength and flexibility along a continuum of primary care.
Higher Community Wellbeing Linked to Reduced CVD Mortality in Study of More than 3000 US Counties
July 06, 2023
Wellbeing is considered a measurable and modifiable community attribute that study authors show is correlated with CV outcomes.
US Maternal Mortality Doubled 1999-2019, Remains Highest Among Black Women
July 05, 2023
The greatest increase over the 10 years was seen in deaths among American Indian and Alaska Native women, according to Institute for Health Metrics and Evaluation data.
Loneliness Linked to Greater Risk for CVD in Individuals with Diabetes
July 05, 2023
The predictive value of loneliness for cardiovascular disease in patients with diabetes was stronger than traditional lifestyle risk factors in large UK Biobank analysis.
Pegozafermin Shows Early Promise in NASH: Phase 2b ENLIVEN Trial Findings
June 30, 2023
Pegozafermin, an investigational long-acting (FGF21) analogue, was associated with fibrosis improvement and NASH resolution in an average of 25% of study participants.
FDA Awards De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Decline in Kidney Function in Adults with Type 2 Diabetes and Early-Stage Kidney Disease
June 30, 2023
KidneyIntelX.dkd, a first-in-class AI-enabled prognostic test, stratifies risk of DKD progression in 5 years and is specific for early stage disease.
E-Cigarettes: US Sales Nearly Double over 2 Years, Youth Prefer Flavored Disposables
June 29, 2023
Sales of e-cigarettes in the US jumped by 46% from 2020-2022; rapid market shifts beg coordinated restrictions to protect public health, says the CDC.
Studies of Novel, Highly Effective Antiobesity Medications Headline 83rd ADA Scientific Sessions
June 28, 2023
Retatrutide, survodutide, orforglipron. The 3 new GLP-1 agonist-based AOMs showed weight loss of up to 20% and are well worth watching.